Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

C Badowski, B He, LX Garmire - NPJ precision oncology, 2022 - nature.com
Cancer ranks as one of the deadliest diseases worldwide. The high mortality rate associated
with cancer is partially due to the lack of reliable early detection methods and/or inaccurate …

A review of prognostic and predictive biomarkers in breast cancer

E Tarighati, H Keivan, H Mahani - Clinical and experimental medicine, 2023 - Springer
Breast cancer (BC) is a common cancer all over the world that affects women. BC is one of
the leading causes of cancer mortality in women, which today has decreased with the …

Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer

Y Shao, X Sun, Y He, C Liu, H Liu - PloS one, 2015 - journals.plos.org
Background & Aims The utility of measuring carcinoembryonic antigen (CEA) and cancer
antigen 15-3 (CA15-3) levels in patients with breast cancer remains controversial. The …

[HTML][HTML] Tumor markers of breast cancer: New prospectives

AM Kabel - Journal of Oncological Sciences, 2017 - Elsevier
Tumor markers are substances produced by the tumors or by other cells of the body in
response to cancer or certain benign conditions. Although most of these markers are made …

[HTML][HTML] Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches

F Davodabadi, M Sarhadi, J Arabpour, S Sargazi… - Journal of Controlled …, 2022 - Elsevier
Breast cancer (BC) is known to be a highly heterogeneous disease that is clinically
subdivided into four primary molecular subtypes, each having distinct morphology and …

Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study

J Li, L Liu, Z Feng, X Wang, Y Huang, H Dai, L Zhang… - Breast Cancer, 2020 - Springer
Background The burden of breast cancer has grown rapidly in China during recent decades.
However, the association between tumor markers (CA15-3, CA125, and CEA) and breast …

Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer

S Wu, Z He, J Zhou, J Sun, F Li, Q Lin, L Guo, H Lin - The Breast, 2014 - Elsevier
The prognostic significance of preoperative carcinoembryonic antigen (CEA) and cancer
antigen 15-3 (CA15-3) levels in breast cancer is controversial. This study evaluated the …

Current immunoassay methods and their applications to clinically used biomarkers of breast cancer

S Jeong, MJ Park, W Song, HS Kim - Clinical biochemistry, 2020 - Elsevier
Breast cancer is the leading cause of cancer-related mortality worldwide, with a higher
incidence in developed countries. The biomarkers for breast cancer such as estrogen …

Salivary biomarkers in the diagnosis of breast cancer: A review

EC Porto-Mascarenhas, DX Assad, H Chardin… - Critical reviews in …, 2017 - Elsevier
Salivary biomarkers could be helpful to characterize breast cancer. Therefore, this review
was performed to evaluate the capability of salivary biological markers in the diagnosis and …

[HTML][HTML] Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer

JS Lee, S Park, JM Park, JH Cho, SI Kim, BW Park - Annals of oncology, 2013 - Elsevier
Background To evaluate the prognostic value of preoperative tumor markers, cancer antigen
15-3 (CA 15-3) and carcinoembryonic antigen (CEA), in breast cancers. Patients and …